• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Preventing Cancer Therapy-Related Cardiotoxicity: Should We be PROACTive or Reactive?

作者信息

Cannata Antonio, McDonagh Theresa

机构信息

School of Cardiovascular Medicine & Sciences, King's College London British Heart Foundation Centre of Excellence, London, United Kingdom.

Department of Cardiology, King's College Hospital NHS Foundation Trust, London, United Kingdom.

出版信息

JACC CardioOncol. 2024 Oct 15;6(5):697-698. doi: 10.1016/j.jaccao.2024.09.001. eCollection 2024 Oct.

DOI:10.1016/j.jaccao.2024.09.001
PMID:39479315
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11520225/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4732/11520225/57692ed0b855/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4732/11520225/57692ed0b855/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4732/11520225/57692ed0b855/ga1.jpg

相似文献

1
Preventing Cancer Therapy-Related Cardiotoxicity: Should We be PROACTive or Reactive?预防癌症治疗相关的心脏毒性：我们应该积极主动还是被动应对？
JACC CardioOncol. 2024 Oct 15;6(5):697-698. doi: 10.1016/j.jaccao.2024.09.001. eCollection 2024 Oct.
2
Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma: The PROACT Clinical Trial.预防乳腺癌和淋巴瘤患者的心脏损伤：PROACT临床试验
JACC CardioOncol. 2024 Aug 27;6(5):684-696. doi: 10.1016/j.jaccao.2024.07.010. eCollection 2024 Oct.
3
Biomarkers and Strain Echocardiography for the Detection of Subclinical Cardiotoxicity in Breast Cancer Patients Receiving Anthracyclines.生物标志物与应变超声心动图在接受蒽环类药物治疗的乳腺癌患者亚临床心脏毒性检测中的应用
J Pers Med. 2023 Dec 14;13(12):1710. doi: 10.3390/jpm13121710.
4
Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients from Southern Sri Lanka: An Echocardiographic Analysis.来自斯里兰卡南部的乳腺癌患者的蒽环类药物心脏毒性：超声心动图分析。
Biomed Res Int. 2020 Nov 12;2020:1847159. doi: 10.1155/2020/1847159. eCollection 2020.
5
Cardiotoxicity of anthracycline-free targeted oncological therapies in HER2-positive breast cancer.HER2阳性乳腺癌中无蒽环类靶向肿瘤治疗的心脏毒性
Oncol Lett. 2021 Feb;21(2):100. doi: 10.3892/ol.2020.12361. Epub 2020 Dec 8.
6
Electrocardiographic and biochemical analysis of anthracycline induced cardiotoxicity in breast cancer patients from Southern Sri Lanka.来自斯里兰卡南部的乳腺癌患者蒽环类抗生素心脏毒性的心电图和生化分析。
BMC Cancer. 2023 Mar 4;23(1):210. doi: 10.1186/s12885-023-10673-0.
7
Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study.在乳腺癌患者接受蒽环类药物治疗期间的神经激素阻断和循环心血管生物标志物：来自 PRADA（蒽环类药物辅助乳腺癌治疗期间预防心功能障碍）研究的结果。
J Am Heart Assoc. 2017 Nov 8;6(11):e006513. doi: 10.1161/JAHA.117.006513.
8
Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT).预防乳腺癌和淋巴瘤患者心脏毒性：一项多中心随机对照试验（PROACT）方案。
BMJ Open. 2022 Dec 30;12(12):e066252. doi: 10.1136/bmjopen-2022-066252.
9
Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity.蒽环类药物诱导的心脏毒性的病理生理学及预防策略
Korean J Intern Med. 2016 Jul;31(4):625-33. doi: 10.3904/kjim.2016.017. Epub 2016 Jul 1.
10
High-sensitive troponin T assay can predict anthracycline- and trastuzumab-induced cardiotoxicity in breast cancer patients.高敏肌钙蛋白 T 检测可预测乳腺癌患者蒽环类药物和曲妥珠单抗相关的心脏毒性。
Breast Cancer. 2017 Nov;24(6):774-782. doi: 10.1007/s12282-017-0778-8. Epub 2017 Apr 22.

引用本文的文献

1
Primary prevention of cardiotoxicity in cancer patients treated with fluoropyrimidines: a randomized controlled trial.接受氟嘧啶治疗的癌症患者心脏毒性的一级预防：一项随机对照试验。
Cardiooncology. 2025 May 17;11(1):48. doi: 10.1186/s40959-025-00344-3.
2
Reply: Enalapril for Preventing Cardiotoxicity After High-Dose Anthracycline Therapy in Breast Cancer and Lymphoma Patients.回复：依那普利预防乳腺癌和淋巴瘤患者大剂量蒽环类药物治疗后的心脏毒性。
JACC CardioOncol. 2025 Apr;7(3):319. doi: 10.1016/j.jaccao.2025.02.002. Epub 2025 Mar 18.

本文引用的文献

1
Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma: The PROACT Clinical Trial.预防乳腺癌和淋巴瘤患者的心脏损伤：PROACT临床试验
JACC CardioOncol. 2024 Aug 27;6(5):684-696. doi: 10.1016/j.jaccao.2024.07.010. eCollection 2024 Oct.
2
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).2022年欧洲心脏病学会（ESC）与欧洲血液学协会（EHA）、欧洲治疗放射学与肿瘤学协会（ESTRO）以及国际心脏肿瘤学会（IC-OS）合作制定的心脏肿瘤学指南。
Eur Heart J Cardiovasc Imaging. 2022 Sep 10;23(10):e333-e465. doi: 10.1093/ehjci/jeac106.
3
Cancer treatment and survivorship statistics, 2022.2022 年癌症治疗和生存统计。
CA Cancer J Clin. 2022 Sep;72(5):409-436. doi: 10.3322/caac.21731. Epub 2022 Jun 23.
4
Association of Titin Variations With Late-Onset Dilated Cardiomyopathy.肌联蛋白变异与晚发性扩张型心肌病的关联。
JAMA Cardiol. 2022 Apr 1;7(4):371-377. doi: 10.1001/jamacardio.2021.5890.
5
Cardiotoxicity of Chemotherapeutic Drugs: An Update and Future Perspectives.化疗药物的心脏毒性：最新进展与未来展望
J Cardiovasc Pharmacol. 2022 Oct 1;80(4):502-514. doi: 10.1097/FJC.0000000000001226.
6
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
7
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.计划接受心脏毒性癌症治疗的癌症患者的基线心血管风险评估：心力衰竭协会欧洲心脏病学会的心脏肿瘤学研究小组与国际心脏肿瘤学会合作的立场声明和新的风险评估工具。
Eur J Heart Fail. 2020 Nov;22(11):1945-1960. doi: 10.1002/ejhf.1920. Epub 2020 Aug 6.
8
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy.非缺血性扩张型心肌病的当代生存趋势和病因特征。
Eur J Heart Fail. 2020 Jul;22(7):1111-1121. doi: 10.1002/ejhf.1914. Epub 2020 Jun 26.
9
Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy.与癌症治疗诱导性心肌病相关的遗传变异。
Circulation. 2019 Jul 2;140(1):31-41. doi: 10.1161/CIRCULATIONAHA.118.037934. Epub 2019 Apr 16.
10
Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960.英国患癌终生风险的趋势：1930年至1960年出生人群的风险比较。
Br J Cancer. 2015 Mar 3;112(5):943-7. doi: 10.1038/bjc.2014.606. Epub 2015 Feb 3.